CMV primary infection in the first trimester — structured oral station (12 minutes)

Opening prompt — "What does this serology result mean, and what is the risk to the fetus?"

Model response, in this order: ^[1]

• "The serology — IgM positive with low-avidity IgG — is consistent with a primary CMV infection in early pregnancy. The low avidity dates the infection to the recent past, which is why it matters now."^[1]
• "The risk of vertical transmission after a primary maternal CMV infection is about 32%, compared with about 1.4% after a recurrent infection — the primary-versus-recurrent distinction is the central counselling point."^[1]
• "Among those infected, severity is highest with first-trimester infection because the fetal brain and developing organs are most vulnerable during organogenesis, even though the absolute transmission rate is lower in the first trimester than later."^[2]

Examiner is listening for: the primary-versus-recurrent distinction, the 32% versus 1.4% figures, and the transmission-versus-severity paradox. ^[1][2]

Probe 1 — "Walk me through the trimester-by-trimester transmission rates."

• "In the Daiminger prospective cohort, transmission after a primary infection was 30.1% in the first trimester, 38.2% in the second trimester, and 72.2% in the third trimester — transmission rises across gestation."^[2]
• "But no symptoms were observed in infected newborns of mothers infected in the third trimester, and the severe-symptom rate was 10.3% overall. Severity falls as transmission rises."^[2]
• "So this woman's first-trimester infection has a lower chance of transmitting than a later one would, but a higher chance of causing severe disease if it does transmit. That is the counselling balance."^[2]

Probe 2 — "Is there a treatment you can offer?"

• "There is now evidence for high-dose oral valaciclovir. For secondary prevention after a first-trimester primary infection, the Faure-Bardon study used valaciclovir 8 g per day — that is 4 g twice daily — for several weeks, and reduced fetal infection on amniotic-fluid PCR with an odds ratio of 0.318."^[4]
• "The same 8 g per day dose was used in the Leruez-Ville in-utero treatment trial for a moderately symptomatic fetus, where it increased the proportion of asymptomatic neonates from 43% to 82%."^[3]
• "I would refer this woman to a fetal medicine unit with CMV expertise to discuss the secondary-prevention valaciclovir option, and I would be honest that this is emerging evidence rather than a routine universal-screening programme — the international consensus does not support universal maternal screening."^[5]

Probe 3 — "How and when would you confirm or exclude fetal infection?"

• "Congenital infection is confirmed by amniotic-fluid CMV PCR, but the timing matters. The amniocentesis should be performed at least 6 weeks after the maternal infection and after 21 weeks gestation, to minimise false negatives from late fetal swallowing and viral shedding timing."^[2][5]
• "An amniocentesis performed too early risks a falsely negative result and false reassurance. Serial fetal ultrasound for the markers of congenital infection — echogenic bowel, ventriculomegaly, growth restriction — runs in parallel."^[5]

Probe 4 — "How would you prevent this in her next pregnancy, or in other pregnant women?"

• "There is no CMV vaccine, so prevention is hygiene counselling. Most primary infections in pregnancy are acquired from young children, and simple behaviours reduce seroconversion."^[6]
• "The counselling: do not share food, drinks, cutlery or pacifiers with young children; wash hands with soap and water after nappy changes, after wiping noses, and after handling toddler toys; kiss young children on the forehead or cheek, not on the lips."^[6]
• "As a childcare worker, she is in the highest-risk group, and this counselling should be reinforced at every visit."^[5][6]

Probe 5 — "What is the long-term outcome of congenital CMV?"

• "Infected infants can develop long-term sequelae, principally sensorineural hearing loss."^[5]
• "That is why audiological follow-up of any congenitally infected infant is essential, even when the newborn appears well."^[5]

Probe 6 — "Tell the woman what is happening, in language she will understand."

This is scored. Demonstrate it out loud rather than describing it. ^[1]

• Sit down, at her eye level, with her partner present if she wishes. Acknowledge her anxiety first.
• Plain words: "The blood test shows you have caught a virus called CMV for the first time, recently in this pregnancy. CMV is a common virus, and in adults it usually causes no harm at all, but because this is your first infection, there is a chance — about one in three — that the virus has passed to the baby."
• The balance: "If the baby is infected, the risk of a serious problem is higher because this happened early in pregnancy, while the baby's brain and organs were developing. That is why we are taking it seriously."
• The plan: "I would like to refer you to our fetal medicine team, who can talk to you about a medicine called valaciclovir that some evidence suggests may reduce the chance of the infection passing to the baby, and about the timing of a test of the fluid around the baby to check whether it is infected."
• Outcome honesty: "Some babies who are infected develop no problems, but some — especially those infected early — can develop hearing loss or other developmental issues, and we would follow the baby's hearing closely after birth."^[1][5]